Orally administered heparins prevent arterial thrombosis in a rat model

Thrombosis and Haemostasis

Volumn 91, Issue 5, 2004, Pages 919-926

  Pinel, Cory ^a   Wice, Sandra M ^a   Hiebert, Linda M ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Arterial thrombosis; Oral; Rats; Tinzaparin; Unfractionated heparin

Indexed keywords

FERRIC CHLORIDE; HEPARIN; SODIUM CHLORIDE; TINZAPARIN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BLOOD FLOWMETRY; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY THROMBOSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TISSUE LEVEL; FILTER; JUGULAR VEIN; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RAT; THROMBOGENESIS; THROMBOSIS PREVENTION; VEIN THROMBOSIS;

EID: 2442540022     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-08-0527     Document Type: Article

References (20)

1. Berkowitz SD, Kosutic G, Marder VJ, et al. Heparin administered orally via a novel carrier system (SNAC) is comparable to SC heparin when used to prevent venous thromboembolic events following elective total hip arthroplasty. Thromb Haemost 1999; Suppl: 492-3.
2. Jaques LB, Hiebert LM, Wice SM. Evidence from endothelium of gastric absorption of heparin and of dextran sulfates 8000. J Lab Clin Med 1991; 117(2): 122-30.
3. 14C-labeled porcine intestinal mucosal heparin following administration to rats by the oral route. Can J Physiol Pharmacol 2000; 78: 307-20.
4. Hiebert LM, Wice SM, Jaques LB. Antithrombotic activity of oral unfractionated heparin. J Cardiovasc Pharmacol 1996; 28: 26-9.
5. Hiebert LM, Ping T, Wice SM. Antithrombotic activity of orally administered low molecular weight heparin (logiparin) in a rat model. Haemostasis 2000; 30: 196-203.
6. Hiebert LM, Wice SM, Ping T, et al. Antithrombotic efficacy in a rat model of the low molecular weight heparin, reviparin sodium, administered by the oral route. Thromb Haemost 2001; 85: 114-8.
7. Hiebert LM. Evidence that Orally Administered Heparins are Absorbed. In: Thrombosis from Bench to Bedside; (in press).
8. Mitchell RN, Cotran RS. Hemodynamic Disorders, Thrombosis and Shock. In: Robbins Basic Pathology. Saunders WB Co. 2002; 113-38.
9. Lockyer S, Kambayashi J. Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. J Cardiovasc Pharmacol 1999; 33: 718-25.
10. Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 1990; 60: 269-80.
11. Leadley RJ, Morgan SR, Bentley R, et al. Pharmacodynamic activity and antithrombotic efficacy of RPR120844, a novel inhibitor of coagulation Factor Xa. J Cardiovasc Pharmacol 2003; 34: 791-9.
12. Hiebert LM, Jaques LB. The observation of heparin on endothelium after injection. Thromb Res 1976; 8: 195-204.
13. Jaques LB, Wice SM, Hiebert LM. Determination of absolute amounts of heparin and of dextran sulfate in plasma in microgram quantities. J Lab Clin Med 1990; 115(4): 422-32.
14. Rivera TM, Leone BA, Paton DR, et al. Oral delivery of heparin in combination with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate: pharmacological considerations. Pharm Res 1997; 14: 1830-4.
15. Lee Y, Kim SH, Byun Y. Oral delivery of new heparin derivatives in rats. Pharm Res 2000; 17: 1259-64.
16. Jiao Y, Ubrich N, Marchand-Arvier M, et al. In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits. Circulation 2002; 105: 230-5.
17. Engelberg H. Orally ingested heparin is absorbed in humans. Clin Appl Thromb Hemost 1995; 1(4): 283-5.
18. Elg M, Gustafsson D, Deinum J. The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis. Thromb Haemost 1997; 78: 1286-92.
19. Hiebert LM. Oral heparins. Clin Lab 2002; 48: 111-6.
20. Lewis SD, Ng AS, Lyle EA, et al. Inhibition of thrombin by peptides containing lysyl-a-keto carbonyl derivatives. Thromb Haemost 1995; 74: 1107-12.